Skip to content

Embecta Corp. EMBC Debt-to-equity

Discontinued — last reported Q4 '21

Debt-to-equity at other companies

Insulet logo
InsuletPODD
0.7×-0.6×
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
5.5×+2.4×
Medtronic logo
MedtronicMDT
0.6×0.0×
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
8.3×-1.5×
Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX
0.0×
ICU Medical logo
ICU MedicalICUI
0.6×-0.2×

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Current ratio2.5×0.0×

Where this comes from

Calculated from Embecta Corp.’s reported figures.

Based on the most recent quarter.

The official record: Embecta Corp.’s 10-Q, filed August 8, 2023, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s debt-to-equity?
Embecta Corp. (EMBC) reported debt-to-equity of 0× in Q3 2021.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.